Current assessment of microhematuria and leukocyturia.
Technical advances in laboratory testing such as sensitive chemical tests and standardized commercial slides have significantly altered our entire approach to urinalysis. In addition, the recognition of the association of microhematuria with urologic neoplasms and the morphologically altered red blood cells with renal parenchymal bleeding is beginning to expand our knowledge of the pathogenesis of microhematuria. Future trends may include a broader range of chemical tests as well as a better understanding of disease processes associated with microhematuria.
U A
UA
Shenoy
D002265:Carboxylic Ester Hydrolases / Q000652:urine; D004796:Clinical Enzyme Tests; D004906:Erythrocyte Count; D006417:Hematuria / Q000473:pathology / Q000652:urine*; D006456:Hemoglobinuria / Q000652:urine; D006470:Hemorrhage / Q000652:urine; D006801:Humans; D007674:Kidney Diseases / Q000652:urine; D007958:Leukocyte Count; D009212:Myoglobinuria / Q000652:urine; D009504:Neutrophils / Q000201:enzymology; D011934:Reagent Strips; D013194:Staining and Labeling; D014570:Urologic Diseases / Q000652:urine*
D011934:Reagent Strips; C021443:leukocyte esterase; D002265:Carboxylic Ester Hydrolases